Immunotherapy for deficient mismatch repair (dMMR) pancreatic ductal adenocarcinoma

被引：1
|
作者：
Ebia, Matthew I. [1 ]
Hitchins, Megan P. [2 ]
Hendifar, Andrew E. [1 ,3 ,4 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA USA
[3] Cedars Sinai Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Dept Med, Div Hematol & Oncol, 8700 Beverly Blvd,Suite 1042AC, Los Angeles, CA 90048 USA
来源：
JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2023年 / 14卷 / 02期
关键词：
Pancreatic ductal adenocarcinoma (PDAC); DNA deficient mismatch repair (DNA dMMR); microsatellite instability (MSI); Lynch syndrome; immunotherapy; CANCER;
D O I：
10.21037/jgo-23-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：1175 / 1177
页数：3
相关论文
共 50 条
  • [1] Investigate the efficacy of immunotherapy for treatment of pancreatic adenocarcinoma (PDAC) with mismatch repair deficiency (dMMR).
    Noor, Arish
    Aguirre, Luis E.
    Blue, Kirsten
    Avriett, Trenton
    Carballido, Estrella M.
    Kim, Richard D.
    Kim, Dae Won
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [2] A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
    Cox, Ronald E., Jr.
    Mahipal, Amit
    Chakrabarti, Sakti
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [3] Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma
    Ahmad-Nielsen, Soz Abdulrahman
    Nielsen, Michael Friberg Bruun
    Mortensen, Michael Bau
    Detlefsen, Sonke
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (06)
  • [4] Mismatch Repair Status as a Predictive Marker in Pancreatic Ductal Adenocarcinoma
    Riazy, Maziar
    Kalloger, Steve
    Sheffield, Brandon
    Li-Chang, Hector
    Scudamore, Charles
    Renouf, Daniel
    Schaeffer, David
    LABORATORY INVESTIGATION, 2015, 95 : 447A - 447A
  • [5] Mismatch Repair Status as a Predictive Marker in Pancreatic Ductal Adenocarcinoma
    Riazy, Maziar
    Kalloger, Steve
    Sheffield, Brandon
    Li-Chang, Hector
    Scudamore, Charles
    Renouf, Daniel
    Schaeffer, David
    MODERN PATHOLOGY, 2015, 28 : 447A - 447A
  • [6] Characterization and clinical outcomes of mismatch repair deficient (dMMR) small bowel adenocarcinoma (SBA).
    Latham, Alicia
    Reidy, Diane Lauren
    Segal, Neil Howard
    Yaeger, Rona
    Ganesh, Karuna
    Connell, Louise Catherine
    Kemeny, Nancy E.
    Shia, Jinru
    Hechtman, Jaclyn Frances
    Srinivasan, Preethi
    Patel, Zalak
    Tkachuk, Kaitlyn
    Berger, Michael F.
    Saltz, Leonard B.
    Cercek, Andrea
    Stadler, Zsofia Kinga
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] DNA mismatch repair deficient (dMMR) endometrial cancer
    Liu, Chia-Hao
    Yang, Szu-Ting
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2022, 61 (05): : 741 - 743
  • [8] Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma
    Grant, Robert C.
    Denroche, Robert
    Jang, Gun Ho
    Nowak, Klaudia M.
    Zhang, Amy
    Borgida, Ayelet
    Holter, Spring
    Topham, James T.
    Wilson, Julie
    Dodd, Anna
    Jang, Raymond
    Prince, Rebecca
    Karasinska, Joanna M.
    Schaeffer, David F.
    Wang, Yifan
    Zogopoulos, George
    Berry, Scott
    Simeone, Diane
    Renouf, Daniel J.
    Notta, Faiyaz
    O'Kane, Grainne
    Knox, Jennifer
    Fischer, Sandra
    Gallinger, Steven
    GUT, 2021, 70 (10) : 1894 - 1903
  • [9] Clinical recommendations on the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair (dMMR) tumors
    Mishima, Saori
    ANNALS OF ONCOLOGY, 2021, 32 : S283 - S283
  • [10] Immunotherapy for pancreatic ductal adenocarcinoma
    Carpenter, Eileen
    Nelson, Sarah
    Bednar, Filip
    Cho, Clifford
    Nathan, Hari
    Sahai, Vaibhav
    di Magliano, Marina Pasca
    Frankel, Timothy L.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 123 (03) : 751 - 759
12345